Transcarent To Acquire Accolade (ACCD) for $7.03 per share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Transcarent To Acquire Accolade
January 8, 2025 8:30 AM ESTCombined company creates industry leading platform with more than 1,400 employer and payer clients, with shared focus on consumer empowerment
Transcarents Generative AI WayFinding and care experiences combined with Accolades Advocacy, Expert Medical Opinion, and Primary Care will deliver on the promise of One Place for Health and Care
Accolade shareholders to receive $7.03 per share in cash
SAN FRANCISCO and SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Transcarent, the One Place for Health and Care, and Accolade (NASDAQ: ACCD), a leader in health... More



